Fibrolux: The Promise of Light Therapy for Fibromyalgia**
Fibrolux is a revolutionary laser therapy device designated to provide temporary relief of pain associated with fibromyalgia. This pain-relieving treatment is approved by the Food and Drug Administration (FDA) for the treatment of fibromyalgia. It delivers optimal doses of light energy using a combination of curated wavelengths, which are designed to address the sensory processing abnormalities in fibromyalgia patients.
Background
Fibromyalgia is a chronic neurological condition characterized by widespread musculoskeletal pain, tenderness, and fatigue. While there is no known cure for fibromyalgia, existing medications and treatments are aimed at managing symptoms. However, many Fibrology patients find that pharmaceutical interventions offer limited effectiveness and come with serious side effects.
Mechanism of Action
Fibrolux laser therapy is believed to work by increasing blood circulation in painful areas. Additionally, it targets the release of neurotransmitters involved in pain perception, promoting a reduction in pain signals. The high-powered beams emitted by the Fibrolux therapy device are focused on specific tender points on the body, which are identified as areas of increased sensitivity in fibromyalgia patients.
Study Findings
A clinical study published in the American Journal of Physical Medicine & Rehabilitation demonstrated the efficacy of Fibrolux therapy in reducing pain and improving quality of life in patients with fibromyalgia. In this study, the majority of patients who received the light treatment experienced a significant decrease in both tender point count and overall pain ratings.
Side Effects
While Fibrolux therapy has been generally well-tolerated, some patients may experience mild side effects such as skin irritation or minor skin irritation. Most notably, the most common side effect reported was pain and itching at the treatment site. None of the reported side effects were severe, and the majority were transient. In clinical trials, no long-term side effects or toxicity were observed.
Cost and Insurance Coverage
The cost of the Fibrolux therapy device is expected to be between $2,000 to $3,000 US dollars, though the exact pricing may vary based on the number of treatment sessions required. At present, insurance coverage for Fibrolux therapy is not widely available, but the company is actively seeking to have it covered by insurance companies.
Professional Recommendation
Dr. Timothy Demchak, from Wabash Valley Health Center, has reported positive results when using the Fibrolux therapy in his patients with fibromyalgia. He states that the combination of laser therapy and aerobic exercise can be particularly beneficial for improving patient outcomes. Dr. Zashin, who is not involved with Fibrolux, suggests that the device could serve as a complementary treatment complementing existing medications and lifestyle recommendations.
****
Fibrolux represents a significant advancement in the treatment of fibromyalgia, offering a non-invasive, drug-free alternative that can provide temporary relief of pain. While additional research is needed to understand the long-term benefits and potential mechanisms, the device is poised to make a meaningful impact on the lives of individuals living with fibromyalgia. As the first laser therapy device cleared by the FDA for the treatment of fibromyalgia, Fibrolux holds great promise for providing a safe and effective option to combat the persistent pain and discomfort associated with this condition. It is crucial for both healthcare providers and patients to recognize the potential benefits of Fibrolux therapy in improving pain management and overall quality of life.
References:
-
Multi Radiance Medical therapeutic laser receives FDA clearance for the treatment of pain associated with fibromyalgia. News release. Multi Radiance Medical. Accessed October 4, 2022.https://www.businesswire.com/news/home/20221004005022/en/Multi-Radiance-Medical-Therapeutic-Laser-Receives-FDA-Clearance-for-The-Treatment-of-Pain-Associated-with-Fibromyalgia
-
FibroLux, a laser-based therapy developed by Multi Radiance Medical, became the first so-called “photoceutical” device approved by the Food and Drug Administration (FDA) to help fibromyalgia patients manage pain.
-
FDA Approves a Laser Therapy Device for Fibromyalgia … Key Takeaways
The FDA approved a laser therapy device called FibroLux to treat fibromyalgia.
Fibromyalgia is characterized by joint and muscle pain. FibroLux can reduce pain by delivering light to cells, increasing energy production, and healing cells.
There’s a new产品 on the market to treat pain associated with纤维肌痛。它既不是药物也不是健康项目——而是一种脉冲光束。
纤维肌痛症是一种影响着全身的广泛肌肉和关节疼痛状况。纤维肌痛症患者通常对普通的疼痛难以耐受，他们可能会经历极度的疲劳和记忆问题。这种疾病在美国影响着大约2%的人。
科学家们还没有找到这种病症的病因或治愈方法。目前，用于治疗纤维肌痛症的药物效果相对较差，且伴随着一些严重的副作用。
“这是一个从未有过选择的人群，一直以来的建议是‘去锻炼、服用这种药物或什么都不做。’那些是你仅有的选择。”道格拉斯·约翰逊，美国理疗与康复医学部副主席兼首席科学事务官说道。
约翰逊说，新的FDA批准意味着为提供快速疼痛缓解又几乎没有任何副作用的治疗方法，增加了选项的数量。
纤维肌痛症治疗仪不是治愈纤维肌痛症的。该公司仅在短短三周内对其有效性进行了测试，这意味着目前尚不清楚这种疗法持续疼痛缓解的效果如何。但是，对于那些已经使用其他治疗方法的患者来说，它可以作为一个有用的补充工具。
该设备适用于家庭使用或作为物理治疗的一部分。每次治疗每个疼痛点只需几秒钟的时间。因此，一次治疗疗程可能从四分钟到五小时不等，具体取决于患者的病情。
纤维肌痛症治疗仪是在一个接受了光疗的患者群体中测试的，另一组是与锻炼计划相结合的患者，还有一个对照组。
他们发现，将光线疗法与锻炼计划结合起来取得了更好的效果。
“有点像双管齐下，如果你愿意的话，可以说它是双重胜利。我们不仅可以控制他们的疼痛，而且我们还可以帮助他们更好地锻炼。”康利公司负责临床开发的高级副总裁乔伊·韦尔奇说道。
康利公司在另一个针对肌肉疼痛的研究中使用了这项技术。研究表明，这种技术可以帮助减少运动引起的疼痛、疲劳、炎症和受伤。
康利公司还有其他旨在减少因运动引起的肌肉疼痛和疲劳的激光疗法产品。
“正常情况下，当你锻炼时，你可能会产生那种“无痛苦得不得了”的观念。但我们说，好的，我们可以用无痛苦的方法获得好的结果。”“我们的目标是为需要的人提供他们负担得起的最好的技术，同时还能确保他们的安全。”
康利公司正在进行更多针对眼部疾病和其他医疗条件的激光疗法设备的临床试验。首席执行官马克斯·卡恩斯基表示，随着更多的研究数据出现，他们将推出更多的产品。
康利公司的纤维肌痛症治疗仪最近获得了FDA的批准，用于治疗纤维肌痛症。康利斯说，纤维肌痛症会影响患者的活动能力、睡眠和生活质量。
康利公司认为，纤维肌痛症是一个复杂的疾病，涉及多个系统和生物学的相互作用。虽然科学家们正在探索纤维肌痛症的潜在原因和生物学机制，但治疗重点始终放在改善患者的症状和生活质量上。
